Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What is the Projected CAGR for the Drug Delivery Devices Market Size from 2025 to 2034?

In recent times, there has been a robust growth in the drug delivery devices market. It is projected that this market, which was valued at $91.03 billion in 2024, will ascend to $95.99 billion in 2025, with a compound annual growth rate (CAGR) of 5.4%. The surge observed in the historic period can be credited to a swift increase in aging population, expansion in healthcare facilities, economic enhancement in the developing markets, and rise in healthcare spending.

The market for drug delivery devices is anticipated to experience robust expansion in the forthcoming years. The market value is projected to reach $122.16 billion in 2029, with a compound annual growth rate (CAGR) of 6.2%. The expansion during this forecast period can be ascribed to the escalating prevalence of chronic diseases, the increased demand for injectables, a surge in the need for drug delivery devices, and the sudden outbreak of severe infections. Significant trends for this forecast period encompass investment in microneedle drug technology for medicine delivery, the exploration and creation of self-injectable drug delivery devices, a focus on mergers and acquisitions and investments in wearable drug delivery devices.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2833&type=smp

What Are the Primary Drivers Supporting the Market Growth of the Drug Delivery Devices Market?

The escalating occurrence of chronic illnesses such as cardiovascular disease, diabetes, cancer and other ailments looks set to propel the market for drug delivery devices. As noted by the National Library of Medicine, a medical library in the US operated by the federal government, the population of individuals in the United States aged 50 and above with at least one chronic condition is anticipated to soar by 99.5% in January 2023. This surge will elevate the number from 71.522 million in 2020 to 142.66 million by 2050. There are diverse drug administration paths for medical drugs and the invention of novel drug delivery systems holds a considerable place in the pharmaceutical sphere. Due to the rising occurrence of these diseases, worldwide research and development (R&D) in drug delivery is on the upswing. Numerous pharmaceutical firms are directing their attention to several drug delivery technologies to achieve superior advantages and improved results for their marketed products. Therefore, the rising occurrence of chronic illnesses is leading to a heightened intake of therapeutic drugs and therapies, which is anticipated to serve as a catalyst for the expansion of the drug delivery devices market.

Which Primary Segments of the Drug Delivery Devices Market Are Driving Growth and Industry Transformations?

The drug delivery devicesmarket covered in this report is segmented –

1) By Route Of Administration: Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery, Nasal Drug Delivery, Transmucosal Drug Delivery, Implantable Drug Delivery

2) By Patient Care Setting: Hospitals, Diagnostic Centers, Ambulatory Surgery Centers/Clinics, Home Care Settings, Other Patient Care Settings

3) By Application: Cancer, Infectious Diseases, Respiratory Diseases, Diabetes, Cardiovascular Diseases, Autoimmune Diseases, Central Nervous System Disorders, Other Applications

Subsegments:

1) By Oral Drug Delivery: Tablets and Capsules, Oral Sprays, Oral Liquids, Oral Disintegrating Tablets

2) By Injectable Drug Delivery: Syringes (manual and auto-disable), Vials and Cartridges, Pen Injectors, Infusion Pumps

3) By Topical Drug Delivery: Creams and Ointments, Transdermal Patches, Gels and Lotions, Powders

4) By Ocular Drug Delivery: Eye Drops, Ocular Inserts, Contact Lens Drug Delivery Systems

5) By Pulmonary Drug Delivery: Metered-Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs), Nebulizers

6) By Nasal Drug Delivery: Nasal Sprays, Nasal Powders, Nasal Drops

7) By Transmucosal Drug Delivery: Buccal Tablets, Sublingual Tablets, Mucoadhesive Films

8) By Implantable Drug Delivery: Drug-Implantable Devices, Biodegradable Implants, Reservoir-based Implants

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=2833&type=smp

Which Regions Are Key Players in the Growth of the #What Are the Primary Drivers Supporting the Market Growth of the Drug Delivery Devices Market?# Market?

North America was the largest region in the drug delivery devices market in 2024. Asia-Pacific was the second-largest region in the global drug delivery devices market. The regions covered in the drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Are the Most Significant Market Trends in the Drug Delivery Devices Market?

Key players in the drug delivery device market, such as major companies, are concentrating their efforts on creating groundbreaking devices like autoinjectors with fully integrated connectivity to maintain their competitive advantage. Autoinjectors are engineered for individual self-administration of a preset medication dosage. For example, in May 2022, Jabil Healthcare, a US-based healthcare manufacturing solutions provider, unveiled the Qfinity autoinjector platform, a recyclable drug delivery tool. Differentiating itself with its simpler, reusable and modular design, the Qfinity autoinjector platform provides an affordable alternative to rivals in the market and encourages eco-friendly drug administration within the pharmaceutical sector. Its flexible design can handle different volumes and viscosities of pharmaceuticals, and it includes a patient-friendly structure that delivers up to 65% lower injection costs compared to top disposable autoinjectors. The robust Qfinity tool can perform over 100 injections and can use 1 mL or 2.25 mL pre-loaded disposable cassettes. Moreover, its lower component usage and decreased material use result in an estimated 65% reduction in injection costs, a 60% smaller carbon footprint, a 50% decrease in manufacturing footprint, and a 70% drop in capital expenditure (CAPEX).

View the full report here:

https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report

What Parameters Are Used to Define the Drug Delivery Devices Market?

Drug delivery devices are used to deliver specific drugs to a specific part of the body to cure diseases. Drug delivery devices used in various patient care settings, such as hospitals, diagnostic centers, clinics, and home care settings, are included in this market.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2833

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model